Pittcon to Participate in International Year of Chemistry (IYC)
22 Jun 2010: Extra activities to celebrate the International Year of Chemistry (IYC) at Pittcon 2011 have been announced. The extra programs include Science Week, which will serve the city of Atlanta and surrounding genomics, and on a more global level, and the Technical Program, which will include sessions on how chemical research is critical for solving global problems involving food, water, health, energy and transportation.
The Pittsburgh Conference
|
Leica Microsystems to Develop an Automated HER2 FISH Test with the Leica BOND Staining Platform
 22 Jun 2010: Leica Microsystems GmbH and Abbott have reached an agreement for Abbott to supply fluorescence in situ hybridization (FISH) probes that target the HER2 gene locus. The probes will be used to develop a fully automated FISH solution for HER2 testing on the Leica Microsystems’ BOND™ an automated advanced staining platform.
Leica Microsystems GmbH
|
Pall Corporation Expands Next Generation AcroPrep™ Advance Filter Plate Portfolio
21 Jun 2010: Pall Corporation has expanded its next generation 96-well filter plate portfolio to include additional membrane options and larger well volumes. These new membrane options and larger wells achieve maximize performance in diagnostic and life sciences research applications.
Pall Life Sciences Laboratory Products
|
Expansion and Differentiation of H7 Human Embryonic Stem Cells in Chemically Defined Medium Using Corning® Synthemax™ Surface
21 Jun 2010: In this application note Corning Synthemax Surface is used to support long-term self-renewal and differentiation of H7 hESCs. Cells demonstrated a stable doubling time, high level of expression of hESC phenotypic markers (Oct4, SSEA4 and TRA-1-60) and normal karyotype. Corning Synthemax Surface also supported successful directed differentiation of H7 cells into functional cardiomyocytes, proving suitability of Corning Synthemax Surface for both expansion and differentiation of hESC culture.
Corning Life Sciences
|
Syngene’s 2D Image Analysis Systems Being Used in Critical Research To Analyse the Efficacy of Novel Treatments for Brain Tumours
 18 Jun 2010: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its Dyversity 2D image analyser and Dymension 2D analysis software are being used at US biopharmaceutical company, the Burzynski Research Institute (BRI), to determine the molecular effects compounds have on brain tumours.
Syngene
|
Bridge4Bio Teams with Instream Partners to Focus on Investment Advice
 18 Jun 2010: Life sciences and biotechnology organizations needing to raise capital or quickly identify corporate partners or merger/acquisition candidates worldwide can now benefit from receiving sound, focused investment advice following a collaborative pact forged between Bridge4Bio, LLC and Instream Partners, a FINRA member and leading investment banking and advisory corporate financial group.
Bridge4Bio, LLC
|
AnaSpec Introduces New SensoLyte uPA & tPA Assay Kits
 17 Jun 2010: AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. These kits, optimized for inhibitor screening, contain high-performance fluorogenic substrates which exhibit high reactivity and low background signal.
AnaSpec Inc.
|
Super Resolution Pioneer to Open MICROSCIENCE 2010
16 Jun 2010: Dr Jennifer Lippincott-Schwartz (NIH, US) – a pioneer of super resolution imaging - will give the opening Plenary Lecture at MICROSCIENCE 2010 in London’s docklands on Tuesday 29th June 2010.
Royal Microscopical Society
|
TAP’s Automated Stem Cell Processing Suite Premiers on Stand 820 at ISSCR
 15 Jun 2010: The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is delighted to announce that for the first time it will be showing its full range of stem cell processing automation, to facilitate the production of high quality stem cells, on Stand 820 at the International Society of Stem Cell Research (ISSCR) Conference.
The Automation Partnership
|
Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity
 15 Jun 2010: Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.
Cellular Dynamics International
|
